Patients in the high Hb group experienced increased risk of composite (death, myocardial infarction, hospitalisation for congestive heart failure, or stroke) events (HR: 1.34 (95% CI: 1.03–1.74); p=0.03) and no improvement in quality of life. This evidence concerns the gene GSTM1 and myocardial infarction.